Hualan Biological Engineering: Revenue and profit fell in Q3 2024, with cash flow and working capital under pressure

About this update from Hualan Biological Engineering Inc. Class A

Q3 2024 revenue and net profit declined sharply year-over-year, with operating cash flow also down. Sales and financial expenses fell, but working capital pressures increased due to higher prepayments and receivables.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Hualan Biological Engineering Inc. Class A